MCBK
Grodzisk Mazowiecki, Poland
Medical clinic in Grodzisk Mazowiecki
Daleka 32, 05-825 Grodzisk Mazowiecki
About MCBK
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
5
4SC AG
1
Abbott Nutrition
1
Hoffmann-La Roche
1
Idorsia Pharmaceuticals Ltd.
1
Rigel Pharmaceuticals
1
Clinical Trials at MCBK
During the past decade, MCBK conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on
average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis
2008-05-01
2009-06-01
Completed
457
SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis
2009-11-01
2011-07-01
Completed
266
Evaluation of an Oral Nutritional Supplement Containing AN777
2011-02-01
2012-09-01
Completed
331
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
2015-09-30
2016-11-25
Completed
309
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
2018-06-18
2022-04-25
Completed
730
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2018-10-29
2020-03-06
Completed
838
Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2020-06-11
2021-07-13
Completed
727
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "MCBK" #1 sponsor was "Pfizer" with 5 trials, followed by "4SC AG" with 1 trials
sponsored, "Abbott Nutrition" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MCBK"
#1 collaborator was "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at MCBK
According to Clinical.Site data, the most researched conditions in "MCBK" are
"Rheumatoid Arthritis" (3 trials), "Atopic Dermatitis" (2 trials), "Dermatitis, Atopic" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "MCBK" in a lesser frequency.
Clinical Trials Intervention Types at MCBK
Most popular intervention types in "MCBK" are "Drug" (9 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Abrocitinib 200 mg" (2 trials), "Abrocitinib 100 mg" (1 trials), "Aprocitentan 12.5 mg" (1 trials) and "Aprocitentan 25 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MCBK
The vast majority of trials in "MCBK" are
10 trials for "All" genders.
Clinical Trials Status at MCBK
Currently, there are NaN active trials in "MCBK".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in MCBK,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MCBK, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".